SERIES A COMMON SHARE PURCHASE WARRANT stellar biotechnologies, inc.Security Agreement • May 30th, 2018 • Stellar Biotechnologies, Inc. • Pharmaceutical preparations • New York
THIS SERIES A COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 29, 2023 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common shares, no par value per share (the “Common Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES A COMMON SHARE PURCHASE WARRANT stellar biotechnologies, inc.Securities Agreement • May 30th, 2018 • Stellar Biotechnologies, Inc. • Pharmaceutical preparations • New York
THIS SERIES A COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 29, 2023 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common shares, no par value per share (the “Common Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • May 30th, 2018 • Stellar Biotechnologies, Inc. • Pharmaceutical preparations
This Warrant Exercise Agreement (this “Agreement”), dated as of May 24, 2018, is by and between Stellar Biotechnologies, Inc., a British Columbia corporation (the “Company”), and the undersigned holder (each, a “Holder” and, collectively, the “Holders”) of warrants to purchase shares of the Company’s common stock, no par value per share (the “Common Stock”), issued by the Company, which warrants are exercisable at an exercise price of $2.65 per share (the “Original Warrants”).
